右雷佐生

Q: 右雷佐生 的 CAS 号是多少？

右雷佐生 的 CAS 登记号为 24584-09-6。

Q: 右雷佐生 属于哪个分类？

所属分类：染料及颜料。

CAS 24584-09-6C11H16N4O4MW 268.27

右雷佐生（CAS 24584-09-6）：分子式 C11H16N4O4、分子量 268.27；类别染料及颜料。

产品描述

右雷佐生（CAS 24584-09-6）是一种染料及颜料原料。其分子式 C11H16N4O4 由 11 个碳、16 个氢、4 个氮、4 个氧组成。分子量约为 268.27。公开物性数据显示其熔点约 191-197 °C、LogP 约 -1.4。作为化工品采购代理与分销渠道，我们可在国内及跨境渠道为右雷佐生寻源比价，并安排小批量试样与批次采购；下单前提供完整 COA、质检报告与合规文件，验收以批次 COA 为准。

规格参数

CAS号24584-09-6

分子式C11H16N4O4

分子量268.27

熔点191-197 °C

LogP-1.4

应用领域Cardioprotective agent、For reducing the incidence and severity of cardiomyopathy associated with doxorubicin administration in women with metastatic breast cancer who have received a cumulative doxorubicin hydrochloride dose of 300 mg/m^2 and would benefit from continued doxorubicin therapy. Also approved for the treatment of extravasation from intravenous anthracyclines、Methods of Manufacturing: Preparation: A. M. Creighton、GB 1234935 eidem、US 3941790 (1971、1976 both to Natl. Res. Dev. Corp.)

类别染料及颜料

用途与场景

登记用途：Cardioprotective agent、For reducing the incidence and severity of cardiomyopathy associated with doxorubicin administration in women with metastatic breast cancer who have received a cumulative doxorubicin hydrochloride dose of 300 mg/m^2 and would benefit from continued doxorubicin therapy. Also approved for the treatment of extravasation from intravenous anthracyclines、Methods of Manufacturing: Preparation: A. M. Creighton、GB 1234935 eidem、US 3941790 (1971、1976 both to Natl. Res. Dev. Corp.)。

采购档案

这个产品是什么

右雷佐生是一种着色或颜料类化合物，登记 CAS 号为 24584-09-6，分子式 C11H16N4O4（分子量 268.27），归属于染料及颜料大类化工原料。

识别信息

登记 CAS 号：24584-09-6

其分子式 C11H16N4O4 由 11 个碳、16 个氢、4 个氮、4 个氧组成。

别名/同义词：右雷佐生 · Dexrazoxane

所属分类：染料及颜料

常见问题

右雷佐生的 CAS 号是多少？

右雷佐生的 CAS 登记号为 24584-09-6。

右雷佐生的分子式与分子量是多少？

分子式 C11H16N4O4，分子量 268.27。

右雷佐生还有哪些别名？

别名/同义词：右雷佐生、Dexrazoxane。

右雷佐生的登记用途是什么？

右雷佐生属于哪个分类？

所属分类：染料及颜料。

如何在 591daili.cn 采购右雷佐生？

请在联系页面提交产品名称、CAS 号与数量，我们作为采购代理在国内及跨境渠道为您寻源比价，安排试样与批次采购，下单前提供 COA 与合规文件。

包装与单证

包装按订单确认，从实验室小包装到吨袋大货，随订单安排而非在页面上写死。每批随货附 COA 分析证书，可另提供 MSDS；若终端用途带有法规限度（食品接触、药品或化妆品），请在询价时说明执行标准，等级按该标准确定。

PubChem 公开数据

右雷佐生（CAS 24584-09-6）的公开数据库记录，列此仅供独立核对。

危险化学品分类与危害说明

Reported hazard statements	H315 (97.7%), H319 (97.7%), H335 (95.3%)

H315 (97.7%): Causes skin irritation [Warning Skin corrosion/irritation]

H319 (97.7%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]

物理形态与操作说明

Solid
Crystals from aqueous methanol/ether
Whitish crystalline powder
Sparingly soluble
Slightly soluble in methanol and ethanol. Insoluble in non polar organic solvents.
溶解度 (mg/mL): 35-43 0.1 N HCl, 25-34 0.1 N NaOH, 6.7-10 0.1 M citrate buffer (pH 4), 8.7-13 0.1 M borate buffer (pH 9)

公开数据库收录的理化数据

熔点	191-197 °C
熔点	193 °C
熔点	191 - 197 °C
溶解度	In water, 10-12 mg/mL at 25 °C
溶解度	1.04e+01 g/L
溶解度	H2O 10 - 12 (mg/mL)
溶解度	0.1 N HCI 35 - 43 (mg/mL)
溶解度	0.1 N NaOH 25 - 34 (mg/mL)
溶解度	10% EtOH 6.7 - 10 (mg/mL)
溶解度	MeOH 1 (mg/mL)

这个物质在各数据库里的编号

CAS Registry Number	24584-09-6
PubChem CID	71384
分子式	C11H16N4O4
IUPAC 名称	4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione
UNII（FDA）	048L81261F

数据库记载的用途

For reducing the incidence and severity of cardiomyopathy associated with doxorubicin administration in women with metastatic breast cancer who have received a cumulative doxorubicin hydrochloride dose of 300 mg/m^2 and would benefit from continued doxorubicin therapy. Also approved for the treatment of extravasation from intravenous anthracyclines.
Preparation: A. M. Creighton, GB 1234935 eidem, US 3941790 (1971, 1976 both to Natl. Res. Dev. Corp.)
Information available in 2005 indicated that Dexrazoxane was used in the manufacture of pharmaceutical preparations in the following countries: Austria, Brazil, Canada, Czech Republic, Denmark, France, Hungary, Israel, Italy, Mexico, Poland, USA (1,2)
Information available in 2005 indicated that Dexrazoxane hydrochloride was used in the manufacture of pharmaceutical preparations in the following countries: Argentina, Brazil, Denmark, France, Hungary, Italy, Poland, Romania, Russian Federation, United States (1) /Dexrazoxane Hydrochloride/
Dexrazoxane, an FDA-approved cardioprotective drug, has been successfully used to ameliorate cardiac toxicity seen in anthracycline-based (e.g., doxorubicin, daunorubicin, epirubicin) chemotherapy recipients for cancer, mainly in advanced breast cancer patients, adult patients with soft tissue sarcomas, or small-cell lung cancer. It is used intravenously in conjunction with the anthracycline of choice to decrease the incidence of cardiomyopathy and congestive heart failure.
Breast Feeding; Lactation; Antineoplastic Agents; Cardioprotectants; Cardiotonic Agents; Enzyme Inhibitors; Topoisomerase II Inhibitors

它在各数据库里的别名

Dexrazoxane; 24584-09-6; Dextrorazoxane; Dexrazoxano; ICRF-187; Dexrazoxanum; ADR-529; Razoxane, d-; 4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione; Razoxane, (s)-; (+)-(S)-4,4'-Propylenedi-2,6-piperazinedione; ADR 529; ICRF 187; (+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane; NSC-169780; NSC 169780

计算机算出的分子描述符

分子量	268.27
XLogP3	-1.4
氢键供体数	2
氢键受体数	6
可旋转键数	3
精确质量	268.11715500
单同位素质量	268.11715500
拓扑极性表面积	98.8
重原子数	19
形式电荷	0

数据库摘要

Dexrazoxane · CAS 24584-09-6 · C11H16N4O4. UNII 048L81261F. 熔点: 191-197 °C; 熔点: 193 °C; 熔点: 191 - 197 °C.

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。

获取右雷佐生报价

供应商：济南圣和化工有限公司 · 一个工作日内回复。

邮件询价 WhatsApp